181 related articles for article (PubMed ID: 36661725)
1. Effect of Percutaneous Endoscopic Gastrostomy on Quality of Life after Chemoradiation for Locally Advanced Nasopharyngeal Carcinoma: A Cross-Sectional Study.
Xu Y; Peng H; Guo Q; Guo L; Peng X; Lin S
Curr Oncol; 2023 Jan; 30(1):1000-1009. PubMed ID: 36661725
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
Xu Y; Chen M; Guo Q; Peng H; Guo L; Zong J; Huang H; Chen B; Xu H; Pan J; Lin S
Oral Oncol; 2021 Oct; 121():105435. PubMed ID: 34271334
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Bian X; Song T; Wu S
Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
[TBL] [Abstract][Full Text] [Related]
4. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma.
Oates JE; Clark JR; Read J; Reeves N; Gao K; Jackson M; Boyer M; O'brien CJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):533-40. PubMed ID: 17576902
[TBL] [Abstract][Full Text] [Related]
6. Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinoma.
Xu Y; Guo Q; Lin J; Chen B; Wen J; Lu T; Xu Y; Zhang M; Pan J; Lin S
Onco Targets Ther; 2016; 9():6835-6841. PubMed ID: 27853378
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Endoscopic Nasopharyngectomy Combined With Low-Dose Radiotherapy for Primary T1-2 Nasopharyngeal Carcinoma.
Zhang B; Li Y; Weng J; Huang B; Ban M; Lan G; Lu Y; Luo J; Qu S; Si Y
Technol Cancer Res Treat; 2021; 20():15330338211011975. PubMed ID: 33896244
[TBL] [Abstract][Full Text] [Related]
8. Impact of changes in psychological resilience during treatment with intensity-modulated radiotherapy on nasopharyngeal carcinoma patients: a prospective study.
Lu N; Qin T; Hu W
Ann Palliat Med; 2022 Jan; 11(1):123-134. PubMed ID: 35144404
[TBL] [Abstract][Full Text] [Related]
9. Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.
Tsai WL; Huang TL; Liao KC; Chuang HC; Lin YT; Lee TF; Huang HY; Fang FM
BMC Cancer; 2014 Nov; 14():856. PubMed ID: 25413127
[TBL] [Abstract][Full Text] [Related]
10. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy.
Zhao C; Chen J; Yu B; Chen X
Int J Radiat Biol; 2014 Oct; 90(10):853-8. PubMed ID: 24758521
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
[TBL] [Abstract][Full Text] [Related]
12. Comparison of treatment compliance and nutritional outcomes among patients with nasopharyngeal carcinoma with and without percutaneous endoscopic gastrostomy during chemoradiation.
Peerawong T; Phungrassami T; Pruegsanusak K; Sangthong R
Asian Pac J Cancer Prev; 2012; 13(11):5805-9. PubMed ID: 23317260
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
[TBL] [Abstract][Full Text] [Related]
14. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
[TBL] [Abstract][Full Text] [Related]
15. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
[TBL] [Abstract][Full Text] [Related]
16. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
Chen J; Liu P; Wang Q; Wu L; Zhang X
Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
[TBL] [Abstract][Full Text] [Related]
17. Trismus, xerostomia and nutrition status in nasopharyngeal carcinoma survivors treated with radiation.
Chen YJ; Chen SC; Wang CP; Fang YY; Lee YH; Lou PJ; Ko JY; Chiang CC; Lai YH
Eur J Cancer Care (Engl); 2016 May; 25(3):440-8. PubMed ID: 25495287
[TBL] [Abstract][Full Text] [Related]
18. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study.
Miao J; Wang L; Ong EHW; Hu C; Lin S; Chen X; Chen Y; Zhong Y; Jin F; Lin Q; Lin S; Hu X; Zhang N; Wang R; Wang C; Guo X; Yit NLF; Shi H; Tan SH; Mai H; Xie C; Chua MLK; Zhao C
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):815-825. PubMed ID: 36872457
[TBL] [Abstract][Full Text] [Related]
19. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
20. Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.
Sommat K; Hussain A; Ong WS; Yit NLF; Khoo JBK; Soong YL; Wee JTS; Fong KW; Tan TWK
Radiother Oncol; 2019 Sep; 138():149-157. PubMed ID: 31265972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
